{"id":"tp-51300","type":"article-newspaper","title":"Gyre Therapeutics Posts $32.9 Million in Q3 Revenue, $0.04 GAAP Loss Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/51300","datePublished":"2026-11-08T02:48:32.000Z","dateModified":"2026-11-08T02:48:32.000Z","language":"en","abstract":"Revenue rose 0.6% year over year, and the company maintained its 2026 revenue guidance at $100.5 million to $111 million.","section":"Business","references":[]}